SPRO
Spero Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.08
−2.70%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 7.71x
- PEG TTM
- —
- Price / book
- 1.42x
- Price / sales
- 1.46x
- Price / cash flow
- 3.21x
Enterprise value
- Enterprise value
- $14.2M
- EV / sales
- 0.33x
- EV / EBITDA
- 1.84x
- EV / EBIT
- 2.35x
- Market cap
- $62.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026